🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Observe the safety and tolerability of the single and multiple doses of 601...
Status
Unknown
Location
Chinese PLA General Hospital of Central Theater.
Start Date
2019-03-08
Trial ID
NCT04151407
Treatments Being Tested
Multicenter study to evaluate the safety and tolerability in patients with ...
Status
Unknown
Location
BeiJing Hospital
Start Date
2018-11-12
Trial ID
NCT04468997
To evaluate the safety and efficacy of intravitreal recombinant humanized a...
Status
Unknown
Location
Peking Union Medical College Hospital
Start Date
2021-06-04
Trial ID
NCT04922151
Treatments Being Tested
To compare the efficacy and safety of recombinant humanized anti-VEGF monoc...
Status
Completed
Location
BeiJing Hospital
Start Date
2022-12-27
Trial ID
NCT05520177
Treatments Being Tested
To evaluate the safety and efficacy of intravitreal recombinant humanized a...
Status
Completed
Location
TianJing Medical University Eye Hospital
Start Date
2021-01-27
Trial ID
NCT04667910
Treatments Being Tested
To evaluate the safety and efficacy of intravitreal recombinant humanized a...
Status
Completed
Location
BeiJing Hospital
Start Date
2021-01-28
Trial ID
NCT04667897
Treatments Being Tested